Malgorzata McMasters

1.1k total citations
18 papers, 120 citations indexed

About

Malgorzata McMasters is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Malgorzata McMasters has authored 18 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Malgorzata McMasters's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Malgorzata McMasters is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Malgorzata McMasters collaborates with scholars based in United States, Netherlands and Italy. Malgorzata McMasters's co-authors include Daniel J. DeAngelo, David Avigan, Jean M. Connors, Christine R. Bryke, Anna Falanga, Ioannis Politikos, Marc Carrier, Vassiliki A. Boussiotis, Jeffrey I. Zwicker and Mandy N. Lauw and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Malgorzata McMasters

17 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malgorzata McMasters United States 7 59 35 27 25 21 18 120
Machiko Kusuda Japan 8 82 1.4× 56 1.6× 13 0.5× 37 1.5× 12 0.6× 38 152
Victoria Nachar United States 8 49 0.8× 64 1.8× 24 0.9× 6 0.2× 12 0.6× 27 138
Emmanouil Nikolousis United Kingdom 8 106 1.8× 44 1.3× 17 0.6× 29 1.2× 25 1.2× 26 174
Clémence Mediavilla France 8 88 1.5× 31 0.9× 26 1.0× 27 1.1× 15 0.7× 18 137
Maria Enza Mitra Italy 4 29 0.5× 42 1.2× 24 0.9× 22 0.9× 13 0.6× 7 116
Omotayo Fasan United States 6 49 0.8× 55 1.6× 17 0.6× 12 0.5× 7 0.3× 15 112
Maximilien Grall France 7 30 0.5× 20 0.6× 13 0.5× 8 0.3× 14 0.7× 17 118
Karine Augeul-Meunier France 7 37 0.6× 46 1.3× 23 0.9× 13 0.5× 7 0.3× 13 108
Mauricio Sarmiento Chile 8 78 1.3× 29 0.8× 15 0.6× 14 0.6× 20 1.0× 23 146
Amro Elshoury United States 6 49 0.8× 17 0.5× 18 0.7× 10 0.4× 4 0.2× 10 94

Countries citing papers authored by Malgorzata McMasters

Since Specialization
Citations

This map shows the geographic impact of Malgorzata McMasters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malgorzata McMasters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malgorzata McMasters more than expected).

Fields of papers citing papers by Malgorzata McMasters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malgorzata McMasters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malgorzata McMasters. The network helps show where Malgorzata McMasters may publish in the future.

Co-authorship network of co-authors of Malgorzata McMasters

This figure shows the co-authorship network connecting the top 25 collaborators of Malgorzata McMasters. A scholar is included among the top collaborators of Malgorzata McMasters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malgorzata McMasters. Malgorzata McMasters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Aubrey, Brandon J., Traci M. Blonquist, Malgorzata McMasters, et al.. (2025). A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. Leukemia Research. 153. 107693–107693. 1 indexed citations
2.
Luskin, Marlise R., Mark A. Murakami, Eunice S. Wang, et al.. (2025). A phase I study of asciminib in combination with dasatinib, prednisone, and blinatumomab for Ph-positive acute leukemia in adults.. Journal of Clinical Oncology. 43(16_suppl). 6509–6509.
3.
Luskin, Marlise R., Mark A. Murakami, Yael Flamand, et al.. (2024). Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. Blood. 145(6). 577–589. 6 indexed citations
4.
Sarangi, Sasmit, David J. Einstein, Malgorzata McMasters, et al.. (2021). Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor. Surgical Neurology International. 12. 237–237. 1 indexed citations
5.
Zwicker, Jeffrey I., Tzu‐Fei Wang, Daniel J. DeAngelo, et al.. (2020). The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis. 18(2). 278–284. 27 indexed citations
6.
McMasters, Malgorzata, Barbra M. Blair, Hillard M. Lazarus, & Carolyn D. Alonso. (2020). Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation. Blood Reviews. 47. 100779–100779. 4 indexed citations
7.
Luskin, Marlise R., Mark A. Murakami, Kristen E. Stevenson, et al.. (2019). A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults. Blood. 134(Supplement_1). 3879–3879. 4 indexed citations
8.
Koreth, John, Haesook T. Kim, Paulina Lange, et al.. (2018). Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results. Haematologica. 103(3). 522–530. 19 indexed citations
9.
Politikos, Ioannis, Malgorzata McMasters, Christine R. Bryke, David Avigan, & Vassiliki A. Boussiotis. (2018). Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor. Blood Advances. 2(12). 1367–1370. 14 indexed citations
10.
11.
Alonso, Carolyn D., David A. Braun, Ishan Patel, et al.. (2017). A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients. Transplant Infectious Disease. 19(4). 14 indexed citations
12.
DeAngelo, Daniel J., Andrew M. Brunner, Lillian Werner, et al.. (2017). A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. American Journal of Hematology. 93(2). 254–261. 10 indexed citations
13.
Steensma, David P., Michael B. Maris, Jay Yang, et al.. (2017). H3B-8800-G0001-101: A first in human phase I study of a splicing modulator in patients with advanced myeloid malignancies.. Journal of Clinical Oncology. 35(15_suppl). TPS7075–TPS7075. 10 indexed citations
14.
Fathi, Amir T., Traci M. Blonquist, Mark J. Levis, et al.. (2016). A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia. Blood. 128(22). 5218–5218. 4 indexed citations
15.
Pyzer, Athalia R., Dina Stroopinsky, Hasan Rajabi, et al.. (2016). Acute Myeloid Leukemia Cells Export c-Myc in Extracellular Vesicles Driving a Proliferation of Immune-Suppressive Myeloid-Derived Suppressor Cells. Blood. 128(22). 703–703. 1 indexed citations
16.
Nahas, Myrna, Dina Stroopinsky, Hasan Rajabi, et al.. (2015). MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid Leukemia. Blood. 126(23). 2473–2473. 2 indexed citations
17.
Pyzer, Athalia R., Dina Stroopinsky, Jacalyn Rosenblatt, et al.. (2014). Myeloid-Derived Suppressor Cells Are Expanded in Patients with AML and Are Dependent on MUC1 Expression. Blood. 124(21). 226–226. 1 indexed citations
18.
McMasters, Malgorzata, et al.. (2007). Primary mediastinal large B-cell lymphoma: a retrospective analysis of rituximab and CHOP chemotherapy. Community Oncology. 4(11). 673–677. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Machiko Kusuda Breakdown of academic impact, for papers by Victoria Nachar Breakdown of academic impact, for papers by Emmanouil Nikolousis Breakdown of academic impact, for papers by Clémence Mediavilla Breakdown of academic impact, for papers by Maria Enza Mitra Breakdown of academic impact, for papers by Omotayo Fasan Breakdown of academic impact, for papers by Maximilien Grall Breakdown of academic impact, for papers by Karine Augeul-Meunier Breakdown of academic impact, for papers by Mauricio Sarmiento Breakdown of academic impact, for papers by Amro Elshoury
Rankless by CCL
2026